Ren Xiaotong, Wang Jie, Li Xuemin, Wu Lingling
Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Huangshan City People's Hospital, Huangshan 245000, China.
J Clin Med. 2022 Sep 22;11(19):5555. doi: 10.3390/jcm11195555.
Our purpose is to evaluate long-term changes in corneal endothelial cells after Ex-PRESS shunt implantation for the treatment of glaucoma in Chinese patients by comparison with the contralateral eye. In this retrospective observational study, glaucoma patients with a single eye undergoing Ex-PRESS shunt implantation surgery were consecutively enrolled. For each patient, the clinical assessment, including corneal endothelial cell density (CECD) before surgery and at 6, 12 months, and at last follow-up (2.43 ± 0.63 years) after surgery was reviewed. The operated eyes were in the study group and the unoperated contralateral eyes were used as the control group to compare the CECD change. A total of 48 subjects (age, 51.02 ± 17.96 years) were included. The follow-up period was 2.08~3.17 years, with an average of 2.43 ± 0.63 years. At the last follow-up after the surgery, the CECD decrease in the operated eyes (5.0%) was similar to that in the contralateral eyes (3.2%) (p = 0.130). There were no significant differences in CECD reduction between the two groups at baseline and each postoperative follow-up (6 months, 12 months and at the last follow-up) (all p > 0.05). The average IOP reduction after the surgery was 50.8%, and the number of IOP-lowering medications was significantly reduced (p < 0.05). In addition, visual acuity showed no significant differences during follow-up (p > 0.05). In this study, we found that the CECD reduction of Ex-PRESS shunt-implanted Chinese eyes was similar to that of contralateral eyes without surgery.
我们的目的是通过与对侧眼进行比较,评估在中国患者中植入Ex-PRESS分流器治疗青光眼后角膜内皮细胞的长期变化。在这项回顾性观察研究中,连续纳入了单眼接受Ex-PRESS分流器植入手术的青光眼患者。对于每位患者,回顾了包括手术前、术后6个月、12个月以及最后一次随访(术后2.43±0.63年)时的角膜内皮细胞密度(CECD)在内的临床评估。手术眼为研究组,未手术的对侧眼作为对照组,以比较CECD的变化。共纳入48名受试者(年龄51.02±17.96岁)。随访期为2.08至3.17年,平均为2.43±0.63年。在手术后的最后一次随访中,手术眼的CECD下降率(5.0%)与对侧眼(3.2%)相似(p = 0.130)。两组在基线及术后各次随访(6个月、12个月和最后一次随访)时CECD降低情况均无显著差异(所有p>0.05)。术后平均眼压降低50.8%,降眼压药物数量显著减少(p<0.05)。此外,随访期间视力无显著差异(p>0.05)。在本研究中,我们发现植入Ex-PRESS分流器的中国患者患眼的CECD降低情况与未手术的对侧眼相似。